Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.

Lopes-Virella MF, Baker NL, Hunt KJ, Lyons TJ, Jenkins AJ, Virella G; DCCT/EDIC Study Group.

Diabetes Care. 2012 Jun;35(6):1333-40. doi: 10.2337/dc11-2040. Epub 2012 Apr 17.

PMID:
22511260
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.

Lopes-Virella MF, Carter RE, Baker NL, Lachin J, Virella G; DCCT/EDIC Research Group.

Nephrol Dial Transplant. 2012 Apr;27(4):1416-23. doi: 10.1093/ndt/gfr454. Epub 2011 Aug 19.

PMID:
21856760
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes.

Lopes-Virella MF, Hunt KJ, Baker NL, Lachin J, Nathan DM, Virella G; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

Diabetes. 2011 Feb;60(2):582-9. doi: 10.2337/db10-0915. Epub 2010 Oct 27.

PMID:
20980456
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Soluble LDL-immune complexes in type 2 diabetes and vascular disease.

Turk Z, Sesto M, Skodlar J, Ferencak G, Turk N, Stavljenić-Rukavina A.

Horm Metab Res. 2002 Apr;34(4):196-201.

PMID:
11987029
[PubMed - indexed for MEDLINE]
6.

Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes.

Lopes-Virella MF, Baker NL, Hunt KJ, Lachin J, Nathan D, Virella G; DCCT/EDIC Research Group.

Atherosclerosis. 2011 Feb;214(2):462-7. doi: 10.1016/j.atherosclerosis.2010.11.012. Epub 2010 Nov 17.

PMID:
21156319
[PubMed - indexed for MEDLINE]
Free PMC Article
7.
8.
9.

The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.

Monnier VM, Sell DR, Strauch C, Sun W, Lachin JM, Cleary PA, Genuth S; DCCT Research Group.

J Diabetes Complications. 2013 Mar-Apr;27(2):141-9. doi: 10.1016/j.jdiacomp.2012.10.004. Epub 2012 Nov 12.

PMID:
23153673
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study.

Lloyd CE, Klein R, Maser RE, Kuller LH, Becker DJ, Orchard TJ.

J Diabetes Complications. 1995 Jul-Sep;9(3):140-8.

PMID:
7548977
[PubMed - indexed for MEDLINE]
11.

Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.

Hunt KJ, Baker N, Cleary P, Backlund JY, Lyons T, Jenkins A, Virella G, Lopes-Virella MF; DCCT/EDIC Research Group.

Atherosclerosis. 2013 Dec;231(2):315-22. doi: 10.1016/j.atherosclerosis.2013.09.027. Epub 2013 Oct 11.

PMID:
24267245
[PubMed - in process]
12.

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.

J Pediatr. 2001 Dec;139(6):804-12.

PMID:
11743505
[PubMed - indexed for MEDLINE]
13.

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

Lyons TJ, Jenkins AJ, Zheng D, Lackland DT, McGee D, Garvey WT, Klein RL.

Invest Ophthalmol Vis Sci. 2004 Mar;45(3):910-8.

PMID:
14985310
[PubMed - indexed for MEDLINE]
Free Article
14.

The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.

Lopes-Virella MF, Hunt KJ, Baker NL, Virella G, Moritz T; VADT Investigators.

Atherosclerosis. 2012 Oct;224(2):526-31. doi: 10.1016/j.atherosclerosis.2012.08.006. Epub 2012 Aug 21.

PMID:
22963984
[PubMed - indexed for MEDLINE]
15.

Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

Romero P, Salvat M, Fernández J, Baget M, Martinez I.

J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.

PMID:
17331857
[PubMed - indexed for MEDLINE]
16.

The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes.

Olsen BS, Sjølie AK, Hougaard P, Johannesen J, Marinelli K, Jacobsen BB, Mortensen HB; Danish Study Group of Diabetes in Childhood.

J Diabetes Complications. 2004 May-Jun;18(3):160-4.

PMID:
15145327
[PubMed - indexed for MEDLINE]
17.

Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.

Lopes-Virella MF, Virella G, Orchard TJ, Koskinen S, Evans RW, Becker DJ, Forrest KY.

Clin Immunol. 1999 Feb;90(2):165-72.

PMID:
10080827
[PubMed - indexed for MEDLINE]
18.
19.

Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

Diabetes Control and Complications Trial Research Group.

Diabetes Care. 2000 Aug;23(8):1084-91.

PMID:
10937502
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.

Miura J, Yamagishi Si, Uchigata Y, Takeuchi M, Yamamoto H, Makita Z, Iwamoto Y.

J Diabetes Complications. 2003 Jan-Feb;17(1):16-21.

PMID:
12505751
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk